Journal of Molecular Biomarkers and Clinical Trials is a peer-reviewed, open access journal that primarily aims to develop knowledge about clinical trials and their impact and related medical research methodologies. Clinical trials are a group of regulations and procedures which are used to determine the safety and efficacy of medications, diagnostic products, devices, and treatment that are intended for human use. These are the research studies involving a group of people to study how new medical approaches work in place.
Biomarkers are the indicators which are used to perform clinical assessment. These are also used to monitor and predict state of health in individuals or across populations to achieve appropriate therapeutic intervention. These biomarkers can be a enzyme, hormone or a molecule, gene, genetic product, that have various activities and functions inside the organism. The different types of biomarkers include; fluorescent biomarkers, obesity biomarkers, pro-inflammatory biomarkers, blood-based biomarkers, hematological biomarkers. The molecular biomarkers are used for diagnosis and prognosis of disease, prediction and calculation of the treatment response. These biomarkers are developed and are validated for their use in drug development process.
Aim and Scope:
The journal aims to include a wide range in the field of clinical trials and to set a common platform for the authors to make their contribution towards the journal. The journal assures for a peer review process for maintaining the quality of publishing.
Original Research article, Review article, Clinical image, Case report, Short communication, Editorial, Letters to editors, etc.